Medical Intelligence Quiz
Challenge Yourself, Build Your Knowledge
Evans syndrome
Question 1 of 5
Topics
| Quiz | |
|---|---|
| Fast Facts Friday: February 22, 2019 | Take Quiz |
| Transformed indolent lymphoma and ASCT | Take Quiz |
| Genes & AML | Take Quiz |
| ALL outcomes in pediatric patients | Take Quiz |
| Guideline updates for non-Hodgkin lymphomas: Part 2 | Take Quiz |
| Guideline updates for non-Hodgkin lymphomas: Part 1 | Take Quiz |
| Classification of adult ALL | Take Quiz |
| HIV-related lymphomas and AHCT | Take Quiz |
| Adult HL treatment | Take Quiz |
| Diagnosis and assessment of ALL | Take Quiz |
| Guideline updates for non-Hodgkin lymphomas: Part 3 | Take Quiz |
| Staging of adult HL | Take Quiz |
| Treatment of adult ALL | Take Quiz |
| Screening & prevention of head & neck cancer | Take Quiz |
| Prognosis of head & neck cancer | Take Quiz |
| Epidemiology & risk factors associated with head & neck cancer | Take Quiz |
| Diagnosis & staging of head & neck cancer | Take Quiz |
| Diagnosis & management of infectious disease syndromes | Take Quiz |
| Evaluation of a neutropenic patient with fever | Take Quiz |
| Myelodysplastic syndrome | Take Quiz |
| Therapeutic approaches to myelodysplastic syndrome | Take Quiz |
Fast Facts Friday
Fast Facts Friday
| Quiz | |
|---|---|
| Fast Facts Friday: February 15, 2019 | Take Quiz |
| Fast Facts Friday: February 8, 2019 | Take Quiz |
| Fast Facts Friday: February 1, 2019 | Take Quiz |
Multiple Myeloma
Multiple Myeloma
| Quiz | |
|---|---|
| Complications of multiple myeloma | Take Quiz |
| Clinical progression from MGUS to multiple myeloma | Take Quiz |
| Clinical evaluation of multiple myeloma | Take Quiz |
| Outcomes of multiple myeloma | Take Quiz |
| Pathogenesis of bone disease in multiple myeloma | Take Quiz |
| Smoldering multiple myeloma | Take Quiz |
| Relapsed and refractory multiple myeloma | Take Quiz |
| Global burden of multiple myeloma | Take Quiz |
| The relationship between obesity and multiple myeloma | Take Quiz |
| Prognosis for multiple myeloma | Take Quiz |
| ELOQUENT-3 trial: The addition of IgG monoclonal antibodies to treat multiple myeloma | Take Quiz |
| Diagnostic intervals in multiple myeloma | Take Quiz |
| Imaging techniques in multiple myeloma | Take Quiz |
| Multiple myeloma signs, symptoms, and diagnosis | Take Quiz |
| Pathophysiology of multiple myeloma | Take Quiz |
| Pathological features of multiple myeloma | Take Quiz |
| Staging multiple myeloma | Take Quiz |
| Diagnostic criteria for multiple myeloma | Take Quiz |
| Multiple myeloma: Diagnosis, staging, and risk stratification | Take Quiz |
| Pathogenesis of multiple myeloma | Take Quiz |
| Multiple myeloma: Epidemiology & features | Take Quiz |
| Myeloma survival: Post-transplant response and minimal residual disease | Take Quiz |
| Multiple myeloma outcomes: Lower- & higher-volume facilities | Take Quiz |
| Multiple myeloma: MRD & survival | Take Quiz |
| Smoldering multiple myeloma in the United States | Take Quiz |
| Prognosis of multiple myeloma | Take Quiz |
| Plasma cell neoplasms: The basics | Take Quiz |
| Treatment of multiple myeloma | Take Quiz |
| Plasma cell neoplasms: MGUS | Take Quiz |
| Clinical features of multiple myeloma | Take Quiz |
| Diagnosis and staging of multiple myeloma | Take Quiz |
Gynecologic Cancer
Gynecologic Cancer
| Quiz | |
|---|---|
| Ovarian cancer risk factors | Take Quiz |
| Incidence of ovarian cancer in the United States | Take Quiz |
| Overview of ovarian cancer | Take Quiz |
| USPSTF Recommendations: Cervical cancer screening | Take Quiz |
| Uterine sarcoma treatment | Take Quiz |
| Uterine sarcoma types & prognosis | Take Quiz |
| Endometrial cancer risk, signs, and symptoms | Take Quiz |
| Endometrial cancer: Prognostic factors | Take Quiz |
| ASCO Guidelines: Primary prevention of cervical cancer | Take Quiz |
| ASCO Guidelines: Cervical cancer screening | Take Quiz |
| Subtypes of endometrial cancer | Take Quiz |
| Screening & serum biomarkers for EOC | Take Quiz |
| Prevention of EOC with RRSO | Take Quiz |
| Diagnosis, evaluation, and treatment of EOC | Take Quiz |
| Diagnosis & screening of endometrial cancer | Take Quiz |
| Risk factors & screening for endometrial cancer | Take Quiz |
| Prevention & screening of ovarian cancer | Take Quiz |
| EOC pathology | Take Quiz |
| Nodal spread & endometrial cancer | Take Quiz |
Renal Cell Carcinoma
Renal Cell Carcinoma
| Quiz | |
|---|---|
| Imaging of metastatic renal cell carcinoma | Take Quiz |
| Cytoreductive nephrectomy and lymphadenectomy in the management of kidney cancer | Take Quiz |
| Renal cell carcinoma subtypes and imaging methods | Take Quiz |
| Managing small renal masses, Part 2 | Take Quiz |
| Managing small renal masses, Part 1 | Take Quiz |
| Transitional cell cancer of the renal pelvis and ureter | Take Quiz |
| Genetics of renal cell carcinoma | Take Quiz |
| Clinical features of renal cell carcinoma | Take Quiz |
| ASCO Guidelines: Management of renal cell masses | Take Quiz |
| RCC subtypes: Risk factors, clinical findings, & imaging | Take Quiz |
| Common RCC subtypes | Take Quiz |
| AUA Guideline: Ablation procedures & RCC follow-up | Take Quiz |
| AUA Guideline: RCC surgical follow-up & active surveillance | Take Quiz |
| Staging & surveillance of RCC | Take Quiz |
| Minimally invasive surgery for RCC | Take Quiz |
| Pathophysiology & prognosis of RCC | Take Quiz |
| Unique patient categories in RCC | Take Quiz |
| Management of localized RCC | Take Quiz |
Sarcoma & GIST
Sarcoma & GIST
| Quiz | |
|---|---|
| Managing alveolar soft-part sarcoma | Take Quiz |
| Alveolar soft-part sarcoma manifestation | Take Quiz |
| Overview of Ewing sarcoma | Take Quiz |
| Sarcoma: Importance of histology | Take Quiz |
| Sarcoma imaging: STS or benign processes? | Take Quiz |
| High-risk sarcomas & chemoradiation | Take Quiz |
| Sarcoma: Radiotherapy benefits | Take Quiz |
| Sarcoma: Radiation and surgical options | Take Quiz |
| Stages of sarcoma | Take Quiz |
| Diagnosing sarcoma | Take Quiz |
| Sarcoma: Disease overview | Take Quiz |
Bleeding Disorders
Bleeding Disorders
| Quiz | |
|---|---|
| Evans syndrome | Take Quiz |
| Serological findings in disseminated intravascular coagulation | Take Quiz |
| Disseminated intravascular coagulation and cancer | Take Quiz |
| Measuring fibrinolysis | Take Quiz |
| Recent advances in the management of sickle cell disease | Take Quiz |
| Current management of polycythemia vera & essential thrombocythemia | Take Quiz |
| Update on the management of chronic neutrophilic leukemia | Take Quiz |
| Transitioning from first-line therapies to treat immune thrombocytopenia | Take Quiz |
| Solid organ transplantation for sickle cell disease | Take Quiz |
| Factor V resistance to activated protein C | Take Quiz |
| Pathophysiology of disseminated intravascular coagulopathy | Take Quiz |
| Immunoglobulin A-associated vasculitis | Take Quiz |
| Hematopoietic stem-cell transplantation for sickle-cell disease | Take Quiz |
| Secondary iron overload | Take Quiz |
| Characteristics of polycythemia vera | Take Quiz |
| Diagnosis and treatment of immune thrombocytopenia | Take Quiz |
| Pathophysiology of hemophilia | Take Quiz |
| Hereditary hemorrhagic telangiectasia | Take Quiz |
| Hypercoagulable states: Clinical features | Take Quiz |
| Pancytopenia: Patient history & features | Take Quiz |
| Sickle cell trait & HBA1c in African Americans | Take Quiz |
| Hemophilia A and B: Characteristics & diagnosis | Take Quiz |
| Sickle cell trait, rhabdomyolysis, and mortality | Take Quiz |
| NHF Guideline: Hemophilia care models | Take Quiz |
| Classification of von Willebrand disease | Take Quiz |
| Treatment of von Willebrand disease | Take Quiz |
| Pathophysiology of hemophilia A and B | Take Quiz |
| Clinical manifestations of hemophilia | Take Quiz |
| GVHD: Laboratory & imaging studies | Take Quiz |
Melanoma
Melanoma
| Quiz | |
|---|---|
| BRAF wild-type advanced melanoma and checkpoint inhibitor efficacy | Take Quiz |
| Uveal melanoma guidelines, Part 2 | Take Quiz |
| Uveal melanoma guidelines, Part 1 | Take Quiz |
| Childhood skin cancer | Take Quiz |
| Etiology & clinical presentation of BCC | Take Quiz |
| Etiology & presentation of squamous cell carcinoma | Take Quiz |
| Uveal choroidal melanoma | Take Quiz |
| Management of metastatic melanoma | Take Quiz |
| Adjuvant treatment of melanoma | Take Quiz |
| Melanoma early diagnosis and staging | Take Quiz |
| Melanoma risk factors | Take Quiz |
| Melanoma: Epidemiology & etiology | Take Quiz |
| Clinical features of melanoma | Take Quiz |
Gastroenterology
Gastroenterology
| Quiz | |
|---|---|
| Diagnosing metastatic gastric cancer | Take Quiz |
| Overview of metastatic gastric cancer | Take Quiz |
| Associations between pruritus, cancer, & race | Take Quiz |
| Symptoms and treatment of stomach cancer | Take Quiz |
| Management of pancreatic adenocarcinoma | Take Quiz |
| Esophageal cancer symptoms, diagnosis, & prognosis | Take Quiz |
| Hepatocellular carcinoma in liver transplant candidates | Take Quiz |
| AASLD Guidelines: Treatment of hepatocellular carcinoma | Take Quiz |
| ACS Guidelines: Colorectal cancer screening for average-risk adults | Take Quiz |
| Hepatocellular carcinoma staging and treatment | Take Quiz |
| Overview of gallbladder cancer | Take Quiz |
| Etiology & treatment of anal cancer | Take Quiz |
| Evaluating hepatocellular carcinoma | Take Quiz |
| Treatment for GI carcinoid tumors | Take Quiz |
| Treatment approaches for pancreatic cancer | Take Quiz |
| Pancreatic cancer prognosis and overall survival | Take Quiz |
| Diagnostics for GI carcinoids: Biochemical markers & imaging | Take Quiz |
| HCC: Prognosis, diagnostic imaging & liver biopsy | Take Quiz |
| Neuroendocrine tumors: Diagnosis | Take Quiz |
| Pancreatic neuroendocrine tumors: Pathogenesis & prognostic factors | Take Quiz |
| Colorectal cancer & endoscopic resection | Take Quiz |
| USPSTF Guidelines: Update on CRC screening | Take Quiz |
| Pathophysiology & prognosis of PDA | Take Quiz |
| Staging, radiographic, & laboratory evaluation of PDA | Take Quiz |
| Bowel preparation before colonoscopy | Take Quiz |
| Bowel cleansing for colonoscopy: Diet, regimens, & rating | Take Quiz |
| Colonoscopy surveillance after screening & polypectomy | Take Quiz |
| Endoscopy in the staging & management of CRC | Take Quiz |
Head & Neck Cancers
Head & Neck Cancers
| Quiz | |
|---|---|
| Risks in thyroid cancer management | Take Quiz |
| Well-differentiated thyroid cancers | Take Quiz |
| Types of primary malignant bone tumors | Take Quiz |
| Oral cancer treatment and premalignant lesions | Take Quiz |
| Risk and prevalence of oropharyngeal cancers | Take Quiz |
| ATA Guidelines: Histopathologic evaluation of thyroidectomy samples in patients with DTC | Take Quiz |
| ATA Guidelines: Secretory products & morphological examination of MTC | Take Quiz |
| ATA Guidelines: Intraoperative voice and parathyroid management & follow-up in patients with DTC | Take Quiz |
| ATA Guidelines: Voice and parathyroid issues in DTC | Take Quiz |
| ATA Guidelines: Lymph node dissection & DTC | Take Quiz |
| ATA Guidelines: Management of medullary thyroid | Take Quiz |
| Thyroid cancer trends in the United States | Take Quiz |
| DTC detection in obese and non-obese patients | Take Quiz |
| Staging: Papillary & follicular thyroid cancer | Take Quiz |
| Prognostic & risk factors of thyroid cancer | Take Quiz |
| Thyroid nodules & thyroid metastases | Take Quiz |
| Postoperative treatment of WDTC | Take Quiz |
| Recurrent thyroid cancer | Take Quiz |
| Thyroid gland malignancies: DTC, MTC, & ATC | Take Quiz |
| Surgical treatment: Stage III & IV papillary & follicular thyroid cancer | Take Quiz |
| The breast-thyroid cancer link | Take Quiz |
| ATA Guidelines: Surgery for thyroid cancer | Take Quiz |
| Impact of low iodine diet in DTC | Take Quiz |
| ATA Guidelines: Preoperative neck ultrasound & laboratory tests for DTC | Take Quiz |
| Epidemiology & clinical presentation of parathyroid carcinoma | Take Quiz |
| Diagnosis & treatment of parathyroid carcinoma | Take Quiz |
| Diagnosis & treatment of medullary thyroid cancer | Take Quiz |
| Thyroid cancer outcomes | Take Quiz |
| Clinical presentation & diagnosis of thyroid cancer | Take Quiz |
| ATA Guidelines: Use of CT, MRI, and PET for neck imaging | Take Quiz |
| ATA Guidelines: Initial management of DTC & neck imaging | Take Quiz |
| Surgical treatment of primary stage differentiated thyroid cancer | Take Quiz |
| Treatment of differentiated thyroid cancer | Take Quiz |
| Types of differentiated thyroid cancer | Take Quiz |
Anemia
Anemia
| Quiz | |
|---|---|
| Transplants for aplastic anemia treatment | Take Quiz |
| Plasma volume and blood biomarkers | Take Quiz |
| Features of aplastic anemia | Take Quiz |
| Hypophosphatemia-associated stomatocytosis and anemia | Take Quiz |
| Recent advances in the management of sickle cell disease | Take Quiz |
| Opioid utilization patterns in individuals with sickle cell disease | Take Quiz |
| Iron management in chemotherapy-induced anemia | Take Quiz |
| Clinical phenotypes of sickle cell disease | Take Quiz |
| Overview of hereditary stomatocytosis | Take Quiz |
| Neurological complications in children with sickle cell | Take Quiz |
| Etiology of sideroblastic anemia | Take Quiz |
| Overview of beta-thalassemia | Take Quiz |
| Overview of aplastic anemia | Take Quiz |
| Overview of alpha thalassemia | Take Quiz |
| Signs, symptoms, and staging of iron deficiency anemia | Take Quiz |
| Pathophysiology of iron deficiency anemia | Take Quiz |
| Alpha thalassemia: Management | Take Quiz |
| Types of alpha thalassemia | Take Quiz |
| Alpha thalassemia: Physical findings & diagnosis | Take Quiz |
| Drug-induced hemolysis: Pathophysiology, diagnosis, & treatment | Take Quiz |
| Prognosis & management of megaloblastic anemia | Take Quiz |
| Acute complications of sickle cell disease | Take Quiz |
| Chronic complications of sickle cell disease | Take Quiz |
| Anemia in adults | Take Quiz |
| Hydroxyurea & transfusion therapy in sickle cell disease | Take Quiz |
| Anemia in children | Take Quiz |
| Diagnosis of anemia | Take Quiz |
| Mechanisms of anemia | Take Quiz |
| Drug-induced hemolysis: Clinical features | Take Quiz |
| Diagnosis of megaloblastic anemia | Take Quiz |
Immunotherapy
Immunotherapy
| Quiz | |
|---|---|
| Checkpoint inhibition for cancer immunotherapy | Take Quiz |
| Biomarkers for checkpoint inhibition in hematologic malignancies | Take Quiz |
| Immunohistochemical markers in non-small cell lung carcinoma | Take Quiz |
| Targeting cancer with the immune system | Take Quiz |
| Biomarkers for immune checkpoint inhibition in lung cancer | Take Quiz |
| Evaluating responses to immunotherapy | Take Quiz |
| Immunopharmacogenomics towards personalized cancer immunotherapy | Take Quiz |
| Tumor escape mechanisms and immunotherapy in NHL | Take Quiz |
| Biomarkers for immune checkpoint inhibition therapy in melanoma | Take Quiz |
| Immune checkpoint inhibitors and survival outcomes | Take Quiz |
| Emerging biomarkers in immunotherapy | Take Quiz |
| Cell-mediated therapy to target lymphoma | Take Quiz |
| Developing predictive biomarkers for immunotherapy | Take Quiz |
| Check-point inhibitors in immunotherapy | Take Quiz |
| Selecting biomarkers for immunotherapy | Take Quiz |
| Cancer tumor markers | Take Quiz |
| Immune checkpoints & non-specific immunotherapies | Take Quiz |
| Monoclonal antibodies, adoptive cell therapy, & cytokines | Take Quiz |
| Targeting inhibitors of immune responses & nonspecific immunotherapy | Take Quiz |
| Active specific immunotherapy | Take Quiz |
| Cancer preventive & cancer treatment vaccines | Take Quiz |
| Gene-expression profiling of tumors for immunotherapy | Take Quiz |
| Non-specific cancer immunotherapies & adjuvants | Take Quiz |
| Cancer cells & the immune system | Take Quiz |
| Cancer treatment: Monoclonal antibodies | Take Quiz |
| Forms of immunotherapy | Take Quiz |
| Breast cancer: Emerging immunotherapy options | Take Quiz |
| Immunotherapy & non-small cell lung cancer | Take Quiz |
| Immune checkpoints & their inhibitors | Take Quiz |
| Immune checkpoint inhibitors & tumors with mismatch repair deficiency | Take Quiz |
| PD-based cancer immunotherapy | Take Quiz |
| The role of TGF-beta in human cancer | Take Quiz |
| Immune checkpoint blockade: Tumor interferon signaling | Take Quiz |
| Efficacy of adoptive T-cell therapy | Take Quiz |
| Targeting the necrosome for cancer therapy | Take Quiz |
| Mechanisms involved in the tumor microenvironment | Take Quiz |
| B-cell receptor CD4+ T cells in cancer immunotherapy | Take Quiz |
| Improving T-cell potency via the CAR spacer | Take Quiz |
| ROR gamma agonists & antitumor immunity | Take Quiz |
| Role of B cell regulation in carcinogenesis | Take Quiz |
| Cancer therapies: Vaccine adjuvants, Part 2 | Take Quiz |
| Cancer therapies: Vaccine adjuvants, Part 1 | Take Quiz |
| Validation of biomarkers to predict cancer immunotherapy response | Take Quiz |
| Immune checkpoint modulators & immune cell therapy | Take Quiz |
| Function of Hippo pathway kinases in cancer | Take Quiz |
| Cancer immunotherapy: Immune checkpoint blockers | Take Quiz |
| Cancer immunotherapy target: Wnt/β-catenin signaling in dendritic cells | Take Quiz |
| Understanding oncolytic viruses | Take Quiz |
| Cancer immunotherapy: Producer T cells – Part 2 | Take Quiz |
| Cancer immunotherapy: Producer T cells – Part 1 | Take Quiz |
| Cancer immunotherapy: Oncolytic viruses | Take Quiz |
| Immune checkpoint blockade in cancer therapy | Take Quiz |
| Cancer immunotherapy: Targeting microRNAs | Take Quiz |
| Cancer immunotherapy: Role of Tcon & Treg | Take Quiz |
| IL-24 in immunotherapy | Take Quiz |
| Key omics modalities for precision oncology | Take Quiz |
| CAR T cell therapy in cancer treatment | Take Quiz |
| Categories of tumor antigens | Take Quiz |
| Checkpoint blockade therapy: Immune monitoring assays | Take Quiz |
| Principles of cancer immunotherapy | Take Quiz |
| PD-1/PD-L1 immune checkpoint blockade therapy | Take Quiz |
| Oncolytic viruses as immunotherapy | Take Quiz |
| Approaches to cancer immunotherapy | Take Quiz |
| Cancer immunotherapy mechanisms, advantages, & disadvantages | Take Quiz |
| Immunotherapy in MIS CRC | Take Quiz |
| Cancer immunotherapy: CAR design | Take Quiz |
| Precision immunotherapy | Take Quiz |
| Molecular mechanisms of immune avoidance | Take Quiz |
| Immunotherapy for brain tumors | Take Quiz |
| Adenosine in the tumor microenvironment | Take Quiz |
| The role of TILs and MILs in cancer therapy | Take Quiz |
| Leveraging the antigenic identity of tumors | Take Quiz |
| Advances in cancer immunotherapy | Take Quiz |
| Novel technologies for cancer immunotherapy | Take Quiz |
| Understanding cancer immunology & immunotherapy | Take Quiz |
| Personalized cancer immunotherapy: Novel immune monitoring | Take Quiz |
| Understanding cancer immunotherapy | Take Quiz |
AML
AML
| Quiz | |
|---|---|
| Aging-associated changes in the hematopoietic system | Take Quiz |
| Leukemic transformation of myeloproliferative neoplasms | Take Quiz |
| Pathophysiology of adult AML | Take Quiz |
| FDA Approval: Oral small molecule inhibitor for AML patients | Take Quiz |
| Remission and recurrence of adult AML | Take Quiz |
| Treatment of neutropenia | Take Quiz |
| Types of neutropenia | Take Quiz |
| Neutropenia etiology | Take Quiz |
| Clonal hematopoiesis & risk for therapy-related cancer | Take Quiz |
| AML: Androgen maintenance therapy & survival | Take Quiz |
| Leukemia: Survival after cord-blood transplant | Take Quiz |
| Telomere length and delayed bone marrow recovery in pediatric AML | Take Quiz |
| Extramedullary disease & AML survival | Take Quiz |
Myelodysplastic Syndrome
Myelodysplastic Syndrome
| Quiz | |
|---|---|
| Aging-associated changes in the hematopoietic system | Take Quiz |
| Managing Ph-positive acute lymphoblastic leukemia | Take Quiz |
| Myelodysplastic syndrome: Diagnosis, risk-stratification, and management | Take Quiz |
| Chronic myelomonocytic leukemia: Diagnosis & management | Take Quiz |
| Myelodysplatic syndrome risk and survival | Take Quiz |
| Etiology of sideroblastic anemia | Take Quiz |
| Pathophysiology of myelodysplastic syndrome | Take Quiz |
| Clonal hematopoiesis & risk for therapy-related cancer | Take Quiz |
| Myelodysplastic syndrome: Genetic mutations & outcomes | Take Quiz |
| Chronic myelomonocytic leukemia: Survival after transplant | Take Quiz |
Hodgkin Lymphoma
Hodgkin Lymphoma
| Quiz | |
|---|---|
| Diagnosis of Hodgkin lymphoma | Take Quiz |
| Hodgkin lymphoma risk and prognostic factors | Take Quiz |
| Management of Hodgkin lymphoma | Take Quiz |
| Pathophysiology of Hodgkin lymphoma | Take Quiz |
Genitourinary Cancer
Genitourinary Cancer
| Quiz | |
|---|---|
| Prognostic factors of bladder cancer | Take Quiz |
| Incidence and histopathology of bladder cancer | Take Quiz |
| Clinical features and diagnosis of bladder cancer | Take Quiz |
| Clinical features of urothelial carcinoma | Take Quiz |
| Risk and prognosis of testicular cancer | Take Quiz |
| Clinical features of testicular cancer | Take Quiz |
| Diagnosis and treatment of prostate cancer | Take Quiz |
| Prostate cancer in the US | Take Quiz |
| ASCO/CCO Guidelines: Prostate cancer & brachytherapy | Take Quiz |
| AUA-SUO Guidelines: BCG relapse & salvage regimens in bladder cancer | Take Quiz |
| AUA-SUO Guidelines: TURBT/Repeat resection & intravesical therapy in bladder cancer | Take Quiz |
| RCC subtypes: Risk factors, clinical findings, & imaging | Take Quiz |
| AUA-SUO Guidelines: Urine markers & TURBT/Repeat resection in bladder cancer | Take Quiz |
| Common RCC subtypes | Take Quiz |
| AUA Guideline: Ablation procedures & RCC follow-up | Take Quiz |
| Testicular cancer: Staging & risk stratification | Take Quiz |
| AUA Guideline: RCC surgical follow-up & active surveillance | Take Quiz |
| AHRQ Review: Management of renal masses & localized renal cancer | Take Quiz |
| Understanding urethral cancer | Take Quiz |
| Staging & surveillance of RCC | Take Quiz |
| Minimally invasive surgery for RCC | Take Quiz |
| Management of penile cancer | Take Quiz |
| Pathophysiology & prognosis of RCC | Take Quiz |
| Risk factors & clinical features of bladder cancer | Take Quiz |
| Unique patient categories in RCC | Take Quiz |
| Management of localized RCC | Take Quiz |
| Serum tumor markers & testicular cancer | Take Quiz |
| Epidemiology & risk factors associated with testicular cancer | Take Quiz |
| AUA Guideline: Follow-up for clinically localized renal neoplasms | Take Quiz |
| Clinical features and pathology of bladder cancer | Take Quiz |
| Treatment options for stage I & II RCC | Take Quiz |
| Treatment options for RCC | Take Quiz |
| RCC tumor characterization: Laboratory & imaging studies | Take Quiz |
| Genetic risk factors associated with RCC | Take Quiz |
| RCC subtypes | Take Quiz |
| Pathology & natural history of renal cancer | Take Quiz |
| RCC: Links & risk factors | Take Quiz |
| Clinical features & management of RCC | Take Quiz |
| Epidemiology & etiology of RCC | Take Quiz |
| Risk factors and pathology of prostate cancer | Take Quiz |
| Prostate cancer: Disease detection | Take Quiz |
| Diagnosis & prognosis of bladder cancer | Take Quiz |
| Classification of renal cell cancer | Take Quiz |
| Staging of testicular cancer | Take Quiz |
| Risk factors & prostate cancer | Take Quiz |
| ASCO/ACS: Prostate cancer survivorship care guidelines | Take Quiz |
| Survival in advanced prostate cancer | Take Quiz |
| Understanding bladder cancer | Take Quiz |
| Treatment of prostate cancer | Take Quiz |
ALL
ALL
| Quiz | |
|---|---|
| Organ involvement in Langerhans cell histiocytosis | Take Quiz |
| Managing Ph-positive acute lymphoblastic leukemia | Take Quiz |
| Guidelines: Diagnostic workup of acute leukemia | Take Quiz |
| NCHS Report: Pediatric cancer rates | Take Quiz |
| Ph-like ALL in adults | Take Quiz |
| Acute leukemia: Epidemiology & pathophysiology | Take Quiz |
| Clinical signs & symptoms of acute leukemia | Take Quiz |
| Initial management & tumor lysis syndrome in acute leukemia | Take Quiz |
Indolent Lymphoma
Indolent Lymphoma
| Quiz | |
|---|---|
| Breast implant-associated anaplastic large cell lymphoma | Take Quiz |
| Pathogenesis of mantle cell lymphoma | Take Quiz |
| Characteristics of splenic marginal zone lymphoma | Take Quiz |
| Transformation of follicular lymphoma | Take Quiz |
| Clinical features of chronic lymphocytic leukemia | Take Quiz |
| Clinical features of mycosis fungoides and Sézary syndrome | Take Quiz |
| Overview of mantle cell lymphoma | Take Quiz |
| mSMART Guidelines: Diagnosis & causes of Waldenstrom macroglobulinemia | Take Quiz |
| Overview of chronic lymphocytic leukemia | Take Quiz |
| About Waldenstrom macroglobulinemia | Take Quiz |
| Mycosis fungoides: Early stages & treatment | Take Quiz |
| Nodal marginal zone lymphoma: Epidemiology & clinical presentation | Take Quiz |
| Splenic marginal zone lymphoma: Features, diagnosis, & management | Take Quiz |
| Indolent B-cell lymphoma: Autologous & allogeneic stem cell transplantation | Take Quiz |
| Waldenström’s macroglobulinemia & stem cell transplantation | Take Quiz |
| Characteristics across indolent NHL subtypes | Take Quiz |
| Mycosis fungoides: Clinical presentation, prognosis, & survival | Take Quiz |
| A subset of indolent lymphomas: Features & outcomes | Take Quiz |
| Mass cytometry study of follicular lymphoma tumors reveals cellular characteristics | Take Quiz |
| Cutaneous B-cell lymphoma: Epidemiology & diagnosis | Take Quiz |
| Marginal zone lymphoma & primary cutaneous anaplastic large cell lymphoma | Take Quiz |
| Indolent lymphoma subtypes: Marginal zone lymphoma | Take Quiz |
| Indolent lymphoma subtypes: Lymphoplasmacytic lymphoma | Take Quiz |
| Indolent lymphoma subtypes: Follicular lymphoma | Take Quiz |
| Waldenström macroglobulinemia: Symptoms & criteria for treatment | Take Quiz |
Patient & Survivor Care
Patient & Survivor Care
| Quiz | |
|---|---|
| Optimal pain management for patients with cancer | Take Quiz |
| Opioids in cancer care | Take Quiz |
| Planning end-of-life care in advanced cancer | Take Quiz |
| Cachexia in cancer | Take Quiz |
| Treatment of neutropenia | Take Quiz |
| Types of neutropenia | Take Quiz |
| Neutropenia etiology | Take Quiz |
| HCT & non-HCT cancer survivors: Morbidity & mortality | Take Quiz |
| ASCO Guidelines: Integrating palliative care | Take Quiz |
| Cancer survivors: Medication use for anxiety & depression | Take Quiz |
Transfusion Medicine
Transfusion Medicine
| Quiz | |
|---|---|
| Whole blood and irradiated blood products | Take Quiz |
| Transfusion medicine and platelets | Take Quiz |
| Platelet products in transfusion medicine | Take Quiz |
| The source of hematopoietic stem cells | Take Quiz |
| Bacterial contamination of platelets | Take Quiz |
| ASCO Guideline Update: Platelet transfusion for patients with cancer | Take Quiz |
| Secondary iron overload | Take Quiz |
| Adverse effects of RBC transfusion | Take Quiz |
| Plasma exchange in therapeutic apheresis | Take Quiz |
| Therapeutic uses of cytapheresis | Take Quiz |
| RBC transfusion | Take Quiz |
| Cochrane Review: Red blood cell transfusion strategies | Take Quiz |
| Platelet transfusion for GI bleeding in patients on antiplatelet agents | Take Quiz |
| AABB Guidelines: RBC transfusion thresholds & storage | Take Quiz |
| Transfusion: Age of blood & mortality | Take Quiz |
Breast Cancer
Breast Cancer
| Quiz | |
|---|---|
| Early stage breast cancer | Take Quiz |
| Breast cancer treatment during pregnancy | Take Quiz |
| Breast cancer: Types of surgery | Take Quiz |
| Circulating tumor cell clusters & metastatic breast cancer outcomes | Take Quiz |
| Breast cancer with leptomeningeal metastasis: Characteristics & outcomes | Take Quiz |
| De novo metastatic breast cancer: Occurrence & outcome by subtype | Take Quiz |
| Metastatic breast cancer: Adapting to changes during treatment | Take Quiz |
| ASCO Guidelines: Adjuvant therapy selection & early-stage breast cancer | Take Quiz |
| HER2 overexpression | Take Quiz |
| Breast cancer: Tissue diagnosis & imaging studies | Take Quiz |
| Early & advanced breast cancer: Use of imaging in evaluation & follow-up | Take Quiz |
| Breast cancer: Circulating tumor cells | Take Quiz |
| Metastatic breast cancer with ESR1 mutation: Clinical management considerations | Take Quiz |
| ASCO Guidelines: Endocrine therapy & HR-positive metastatic breast cancer | Take Quiz |
| ASCO Guidelines: HR-positive breast cancer & adjuvant endocrine therapy | Take Quiz |
| ASCO/SSO/ASTRO Consensus Guideline: Margins for breast-conserving surgery with WBRT in DCIS | Take Quiz |
| ASCO Guidelines: Use of biomarkers to guide therapy in early-stage invasive BC--Part 2 | Take Quiz |
| ASCO/CAP Guidelines: HER2 and FISH testing | Take Quiz |
| Factors related to breast cancer surgery choices | Take Quiz |
| Obesity & postmenopausal breast cancer risk | Take Quiz |
| Breast conservation & neoadjuvant therapy | Take Quiz |
| Oophorectomy & breast cancer | Take Quiz |
Preventive Care
Preventive Care
| Quiz | |
|---|---|
| FDA Approval: Expanded use of Gardasil 9 | Take Quiz |
Thrombosis
Thrombosis
| Quiz | |
|---|---|
| Measuring fibrinolysis | Take Quiz |
| Pathophysiology of antiphospholipid syndrome | Take Quiz |
| Current management of polycythemia vera & essential thrombocythemia | Take Quiz |
| Clinical manifestations of cryoglobulinemia | Take Quiz |
| Vitamin D and thrombosis in systemic lupus | Take Quiz |
| Transitioning from first-line therapies to treat immune thrombocytopenia | Take Quiz |
| Immunoglobulin A-associated vasculitis | Take Quiz |
| Protein C deficiency | Take Quiz |
| Characteristics of polycythemia vera | Take Quiz |
| Diagnosis and treatment of immune thrombocytopenia | Take Quiz |
| Characteristics of essential thrombocythemia | Take Quiz |
| Pathogenesis of immune thrombocytopenia | Take Quiz |
| ISTH Guidance Statement: Identifying & preventing VTE in pediatric cancer | Take Quiz |
| Hypercoagulable states: Clinical features | Take Quiz |
| ASH Guidelines: Subsequent management of ITP | Take Quiz |
| ASH Guidelines: Initial management of immune thrombocytopenia | Take Quiz |
| ASH Guidelines: Typical features & diagnosis of immune thrombocytopenia | Take Quiz |
| Guideline: Antithrombotic therapy for VTE, Part 2 | Take Quiz |
| Guideline: Antithrombotic therapy for VTE, Part 1 | Take Quiz |
Pediatrics
Pediatrics
| Quiz | |
|---|---|
| Childhood skin cancer | Take Quiz |
| Unusual cancers of childhood | Take Quiz |
| Retinoblastoma treatment and survival | Take Quiz |
| Clinical features of retinoblastoma | Take Quiz |
HIV
HIV
| Quiz | |
|---|---|
| HIV: Diarrheal alimentary tract disease, Part 1 | Take Quiz |
Rare Diseases
Rare Diseases
| Quiz | |
|---|---|
| Clinical features of thymoma and thymic carcinoma | Take Quiz |
| Unusual cancers of childhood | Take Quiz |
| Cellular classification of thymoma and thymic carcinoma | Take Quiz |
| Overview of Ewing sarcoma | Take Quiz |
| Adrenocortical carcinoma treatment | Take Quiz |
| Treatment approaches for pancreatic cancer | Take Quiz |
| Pancreatic cancer prognosis and overall survival | Take Quiz |
CNS/Brain Cancer
CNS/Brain Cancer
| Quiz | |
|---|---|
| Primary CNS lymphoma pathophysiology | Take Quiz |
| Pituitary tumors: Signs & symptoms | Take Quiz |
| Types of gliomas | Take Quiz |
| In the News: Glioblastoma | Take Quiz |
Neuro-oncology
Neuro-oncology
| Quiz | |
|---|---|
| Primary CNS lymphoma pathophysiology | Take Quiz |
| Diagnosis and treatment of pheochromocytoma | Take Quiz |
| Clinical features of pheochromocytoma | Take Quiz |
CML
CML
| Quiz | |
|---|---|
| Overview of chronic myelogenous leukemia | Take Quiz |
| CML: TKI adherence | Take Quiz |
Clinical Guidelines
Clinical Guidelines
| Quiz | |
|---|---|
| AASLD Guidelines: Treatment of hepatocellular carcinoma | Take Quiz |
| ACS Guidelines: Colorectal cancer screening for average-risk adults | Take Quiz |
| ASCO Guideline Update: Platelet transfusion for patients with cancer | Take Quiz |
| CHEST Guidelines for lung cancer screening | Take Quiz |
| ASCO Guidelines: Primary prevention of cervical cancer | Take Quiz |
| ASCO/CCO Guidelines: Prostate cancer & brachytherapy | Take Quiz |
| ASCO Guidelines: Cancer treatment & cardiac dysfunction risk | Take Quiz |
| Cochrane Review: Red blood cell transfusion strategies | Take Quiz |
| 2017 ASCO Quality Symposium highlights | Take Quiz |
| Guideline: Antithrombotic therapy for VTE, Part 2 | Take Quiz |
| ASCO Guidelines: Management of renal cell masses | Take Quiz |
| ATA Guidelines: Intraoperative voice and parathyroid management & follow-up in patients with DTC | Take Quiz |
| ATA Guidelines: Voice and parathyroid issues in DTC | Take Quiz |
| ASCO Guidelines: Integrating palliative care | Take Quiz |
| ATA Guidelines: Lymph node dissection & DTC | Take Quiz |
| ASCO Guidelines: Cervical cancer screening | Take Quiz |
| ASBMT Guidelines: Autologous progenitor cell transplant | Take Quiz |
| AABB Guidelines: RBC transfusion thresholds & storage | Take Quiz |
| AUA-SUO Guidelines: BCG relapse & salvage regimens in bladder cancer | Take Quiz |
| AUA-SUO Guidelines: TURBT/Repeat resection & intravesical therapy in bladder cancer | Take Quiz |
| ASBMT Guidelines: Autologous & allogeneic HCT considerations in special populations & comorbidities | Take Quiz |
| AUA-SUO Guidelines: Urine markers & TURBT/Repeat resection in bladder cancer | Take Quiz |
| ASBMT Guidelines: Allogeneic progenitor cell transplant | Take Quiz |
| Common RCC subtypes | Take Quiz |
| AUA-SUO Guidelines: Diagnosis of non-muscle invasive bladder cancer | Take Quiz |
| ASCO Guidelines: Adjuvant therapy selection & early-stage breast cancer | Take Quiz |
| AUA Guideline: Ablation procedures & RCC follow-up | Take Quiz |
| NHF Guideline: Hemophilia care models | Take Quiz |
| Acute complications of sickle cell disease | Take Quiz |
| Chronic complications of sickle cell disease | Take Quiz |
| Hydroxyurea & transfusion therapy in sickle cell disease | Take Quiz |
| ASCO Guidelines: Endocrine therapy & HR-positive metastatic breast cancer | Take Quiz |
| ASCO Guidelines: HR-positive breast cancer & adjuvant endocrine therapy | Take Quiz |
| ASCO/SSO/ASTRO Consensus Guideline: Margins for breast-conserving surgery with WBRT in DCIS | Take Quiz |
| AUA Guideline: RCC surgical follow-up & active surveillance | Take Quiz |
| ASCO Guidelines: Use of biomarkers to guide therapy in early-stage invasive BC--Part 2 | Take Quiz |
| AUA Guideline: Follow-up for clinically localized renal neoplasms | Take Quiz |
| ATA Guidelines: Surgery for thyroid cancer | Take Quiz |
| ATA Guidelines: Preoperative neck ultrasound & laboratory tests for DTC | Take Quiz |
| ATA Guidelines: Use of CT, MRI, and PET for neck imaging | Take Quiz |
| ATA Guidelines: Initial management of DTC & neck imaging | Take Quiz |
| Bowel preparation before colonoscopy | Take Quiz |
| Bowel cleansing for colonoscopy: Diet, regimens, & rating | Take Quiz |
| Colonoscopy surveillance after screening & polypectomy | Take Quiz |
| Endoscopy in the staging & management of CRC | Take Quiz |
| Risk factors & prostate cancer | Take Quiz |
| ASCO/ACS: Prostate cancer survivorship care guidelines | Take Quiz |
Practice Management
Practice Management
| Quiz | |
|---|---|
| Cancer estimates & incidence, 2018 | Take Quiz |
| Principles of nutrition in cancer | Take Quiz |
Oncology
Oncology
| Quiz | |
|---|---|
| ACS Guidelines: Colorectal cancer screening for average-risk adults | Take Quiz |
| CHEST Guidelines for lung cancer screening | Take Quiz |
| Active specific immunotherapy | Take Quiz |
| ASCO Guidelines: Primary prevention of cervical cancer | Take Quiz |
| ASCO/CCO Guidelines: Prostate cancer & brachytherapy | Take Quiz |
| NSCLC: Delayed chemo & survival after surgery | Take Quiz |
| ASCO Guidelines: Cancer treatment & cardiac dysfunction risk | Take Quiz |
| PD-based cancer immunotherapy | Take Quiz |
| Lung cancer: The role of imaging studies & chest CT | Take Quiz |
| 2017 ASCO Quality Symposium highlights | Take Quiz |
| USPSTF Guidelines: Update on CRC screening | Take Quiz |
| ASCO Guidelines: Management of renal cell masses | Take Quiz |
| ASCO Guidelines: Integrating palliative care | Take Quiz |
| ATA Guidelines: Lymph node dissection & DTC | Take Quiz |
| ASCO Guidelines: Cervical cancer screening | Take Quiz |
| AUA-SUO Guidelines: BCG relapse & salvage regimens in bladder cancer | Take Quiz |
| AUA-SUO Guidelines: TURBT/Repeat resection & intravesical therapy in bladder cancer | Take Quiz |
| AUA-SUO Guidelines: Urine markers & TURBT/Repeat resection in bladder cancer | Take Quiz |
| Common RCC subtypes | Take Quiz |
| AUA-SUO Guidelines: Diagnosis of non-muscle invasive bladder cancer | Take Quiz |
| ASCO Guidelines: Adjuvant therapy selection & early-stage breast cancer | Take Quiz |
| AUA Guideline: Ablation procedures & RCC follow-up | Take Quiz |
| ASCO Guidelines: Endocrine therapy & HR-positive metastatic breast cancer | Take Quiz |
| ASCO Guidelines: HR-positive breast cancer & adjuvant endocrine therapy | Take Quiz |
| ASCO/SSO/ASTRO Consensus Guideline: Margins for breast-conserving surgery with WBRT in DCIS | Take Quiz |
| AUA Guideline: RCC surgical follow-up & active surveillance | Take Quiz |
| ASCO Guidelines: Use of biomarkers to guide therapy in early-stage invasive BC--Part 2 | Take Quiz |
| AUA Guideline: Follow-up for clinically localized renal neoplasms | Take Quiz |
| ATA Guidelines: Surgery for thyroid cancer | Take Quiz |
| ATA Guidelines: Preoperative neck ultrasound & laboratory tests for DTC | Take Quiz |
| ATA Guidelines: Use of CT, MRI, and PET for neck imaging | Take Quiz |
| ATA Guidelines: Initial management of DTC & neck imaging | Take Quiz |
| Bowel preparation before colonoscopy | Take Quiz |
| Bowel cleansing for colonoscopy: Diet, regimens, & rating | Take Quiz |
| Colonoscopy surveillance after screening & polypectomy | Take Quiz |
| Endoscopy in the staging & management of CRC | Take Quiz |
| Risk factors & prostate cancer | Take Quiz |
| ASCO/ACS: Prostate cancer survivorship care guidelines | Take Quiz |
Hematology
Hematology
| Quiz | |
|---|---|
| ASCO Guideline Update: Platelet transfusion for patients with cancer | Take Quiz |
| Cochrane Review: Red blood cell transfusion strategies | Take Quiz |
| Guideline: Antithrombotic therapy for VTE, Part 2 | Take Quiz |
| ASBMT Guidelines: Autologous progenitor cell transplant | Take Quiz |
| AABB Guidelines: RBC transfusion thresholds & storage | Take Quiz |
| ASBMT Guidelines: Autologous & allogeneic HCT considerations in special populations & comorbidities | Take Quiz |
| ASBMT Guidelines: Allogeneic progenitor cell transplant | Take Quiz |
| NHF Guideline: Hemophilia care models | Take Quiz |
Cellular Therapy
Cellular Therapy
| Quiz | |
|---|---|
| Solid organ transplantation for sickle cell disease | Take Quiz |
| Hematopoietic stem-cell transplantation for sickle-cell disease | Take Quiz |
| Hematopoietic stem cell transplantation | Take Quiz |
| Rosai-Dorfman disease | Take Quiz |
| Prognostic value of hematopoietic cell transplant comorbidity index | Take Quiz |
| Myelodysplastic syndrome: Genetic mutations & outcomes | Take Quiz |
| HSC donors & health-related quality of life | Take Quiz |
| HSCT outcomes & vancomycin-resistant enterococcus colonization & bacteremia | Take Quiz |
| Double-hit lymphomas: Outcomes after ASCT | Take Quiz |
Lung Cancer
Lung Cancer
| Quiz | |
|---|---|
| CHEST Guidelines for lung cancer screening | Take Quiz |
| NSCLC: Delayed chemo & survival after surgery | Take Quiz |
| EGFR tyrosine kinase inhibition and lung cancer | Take Quiz |
| Lung cancer: The role of imaging studies & chest CT | Take Quiz |
| Understanding lung cancer | Take Quiz |
| Advanced & previously treated NSCLC: The OAK & POPLAR trials by Bobby Daly, MD, MBA | Take Quiz |
| PD-L1-Positive NSCLC and KEYNOTE-024, by Bobby Daly, MD, MBA | Take Quiz |
| Pathology & clinical presentation of small cell lung cancer | Take Quiz |
| Staging & imaging of small cell lung cancer | Take Quiz |
| Treatment of stage IIIA NSCLCs | Take Quiz |
| RAS mutations in NSCLC by Kevin Wood, MD | Take Quiz |
| Treatment of early-stage NSCLCs | Take Quiz |
| Clinical evaluation of single pulmonary nodules | Take Quiz |
| NSCLC risk and subtypes | Take Quiz |
| Lung cancer pathology | Take Quiz |
Nonmelanoma Skin Cancer
Nonmelanoma Skin Cancer
| Quiz | |
|---|---|
| Merkel cell carcinoma treatment | Take Quiz |
| Merkel cell carcinoma pathogenesis | Take Quiz |
| First FDA-approved Merkel cell carcinoma treatment | Take Quiz |
T Cell Lymphomas
T Cell Lymphomas
| Quiz | |
|---|---|
| Lymphocytopenia: Signs & symptoms, diagnosis, & treatment | Take Quiz |
| Physical findings of mycosis fungoides | Take Quiz |
GI Oncology
GI Oncology
| Quiz | |
|---|---|
| Pancreatic neuroendocrine tumors: Pathogenesis & prognostic factors | Take Quiz |
| Colorectal cancer & endoscopic resection | Take Quiz |
| USPSTF Guidelines: Update on CRC screening | Take Quiz |
| Risk factors & screening for gastric cancers | Take Quiz |
| Risk factors associated with PDA | Take Quiz |
| Diagnostic laparoscopy & management of PDA | Take Quiz |
| Management of PDA & metastatic disease | Take Quiz |
| Treatment of esophageal cancer | Take Quiz |
| Pathology & staging workup of esophageal cancer | Take Quiz |
| Diagnosing PDA: Imaging & aspiration/biopsy | Take Quiz |
| Clinical presentation & diagnosis of esophageal cancer | Take Quiz |
| Epidemiology & etiology of esophageal cancer | Take Quiz |
| Gastric cancer prevention | Take Quiz |
| Rectal cancer: Neoadjuvant therapy vs surgery | Take Quiz |
| Adenoma detection rates in CRC | Take Quiz |
| Preoperative chemotherapy & colorectal cancer | Take Quiz |
| Familial adenomatous polyposis & CRC | Take Quiz |
| Screening of CRC | Take Quiz |
| Colonoscopy: Optimizing adequate bowel cleansing | Take Quiz |
| ASCO Guidelines: Surveillance protocol for survivors of CRC | Take Quiz |
| Epidemiology & risk factors of CRC | Take Quiz |
| Genetic evaluation & management of Lynch syndrome | Take Quiz |
| Laparoscopic resection vs surgery for rectal cancer | Take Quiz |
| Risk factors & prognosis of rectal cancer | Take Quiz |
| Understanding hereditary CRC syndromes: Part 2 | Take Quiz |
| Colorectal cancer screening: Flexible sigmoidoscopy | Take Quiz |
Aggressive Lymphomas
Aggressive Lymphomas
| Quiz | |
|---|---|
| Double-hit lymphomas: Outcomes after ASCT | Take Quiz |
| HCV: Increased non-Hodgkin lymphoma risk? | Take Quiz |
| Non-Hodgkin lymphoma risk & HIV-Hepatitis coinfection | Take Quiz |
CLL
CLL
| Quiz | |
|---|---|
| CLL & minimal residual disease status | Take Quiz |
| CLL, genetic aberrations, & the elderly | Take Quiz |
| Molecular prognostic indicators in CLL | Take Quiz |
| CLL management & prognosis | Take Quiz |
| Diagnosis, classification, & prognostic factors of CLL | Take Quiz |
| CLL: Risk factors & prognostic factors | Take Quiz |
| Staging CLL | Take Quiz |
| Treatment of CLL | Take Quiz |
| Understanding CLL | Take Quiz |
| CLL: Risk factors & epidemiology | Take Quiz |
| Understanding familial CLL | Take Quiz |
| Clinical manifestations of CLL | Take Quiz |
| Diagnosis of CLL | Take Quiz |
Case-Based Quizzes
Case-Based Quizzes
| Quiz | |
|---|---|
| Advanced & previously treated NSCLC: The OAK & POPLAR trials by Bobby Daly, MD, MBA | Take Quiz |
| PD-L1-Positive NSCLC and KEYNOTE-024, by Bobby Daly, MD, MBA | Take Quiz |
Metastatic Breast Cancer
Metastatic Breast Cancer
| Quiz | |
|---|---|
| De novo metastatic breast cancer: Occurrence & outcome by subtype | Take Quiz |
| Metastatic breast cancer: Adapting to changes during treatment | Take Quiz |
| Metastatic breast cancer with ESR1 mutation: Clinical management considerations | Take Quiz |
| ASCO Guidelines: Endocrine therapy & HR-positive metastatic breast cancer | Take Quiz |
Mantle Cell Lymphoma
Mantle Cell Lymphoma
| Quiz | |
|---|---|
| MCL: Epidemiology, subtypes, & diagnosis | Take Quiz |
| MCL: Diagnosis, treatment, & prognosis | Take Quiz |
Lymphoma & Plasma Cell Disorders
Lymphoma & Plasma Cell Disorders
| Quiz | |
|---|---|
| Treatment of adult HL | Take Quiz |
| Diagnosis & pathogenesis of primary CNS lymphoma | Take Quiz |
| Indolent & aggressive NHL | Take Quiz |
| Cellular classification & treatment of NHL | Take Quiz |
| Understanding NHL | Take Quiz |
| Prognosis of primary CNS lymphoma | Take Quiz |
Leukemia, Myelodysplasia, Transplantation
Leukemia, Myelodysplasia, Transplantation
| Quiz | |
|---|---|
| Testing & mutational analysis in chronic myeloid leukemia | Take Quiz |